AlphaQuest LLC increased its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 2,137.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 13,938 shares of the medical device company's stock after purchasing an additional 13,315 shares during the quarter. AlphaQuest LLC's holdings in Cooper Companies were worth $1,281,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. OFI Invest Asset Management bought a new stake in shares of Cooper Companies in the 4th quarter valued at about $34,000. Rialto Wealth Management LLC acquired a new stake in shares of Cooper Companies during the 4th quarter worth approximately $215,000. Machina Capital S.A.S. increased its holdings in Cooper Companies by 363.5% in the fourth quarter. Machina Capital S.A.S. now owns 16,936 shares of the medical device company's stock valued at $1,557,000 after buying an additional 13,282 shares in the last quarter. Andra AP fonden purchased a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $1,030,000. Finally, Callan Family Office LLC purchased a new position in Cooper Companies during the fourth quarter valued at $381,000. Institutional investors own 24.39% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms have weighed in on COO. Citigroup decreased their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Morgan Stanley lowered their price objective on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Friday, December 6th. Piper Sandler reissued an "overweight" rating and set a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus decreased their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Finally, StockNews.com lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $111.89.
Check Out Our Latest Stock Report on Cooper Companies
Cooper Companies Trading Down 1.0 %
Cooper Companies stock traded down $0.79 during trading on Wednesday, hitting $80.25. The company's stock had a trading volume of 393,113 shares, compared to its average volume of 1,694,891. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market capitalization of $16.02 billion, a price-to-earnings ratio of 41.15, a P/E/G ratio of 2.25 and a beta of 1.02. The stock's fifty day moving average is $91.93 and its 200 day moving average is $99.25. The Cooper Companies, Inc. has a 1-year low of $78.43 and a 1-year high of $112.38.
Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.
About Cooper Companies
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Further Reading
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
